Qube Research & Technologies (QRT)’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-2
Closed -$56 3553
2024
Q2
$56 Sell
2
-560
-100% -$15.3K ﹤0.01% 3494
2024
Q1
$15.5K Hold
562
﹤0.01% 3738
2023
Q4
$13.7K Hold
562
﹤0.01% 3555
2023
Q3
$12.6K Buy
+562
New +$13.6K ﹤0.01% 3274
2021
Q3
Sell
-7,446
Closed -$345K 2378
2021
Q2
$345K Buy
+7,446
New +$337K ﹤0.01% 1493

Other funds holding FFTY

Qube Research & Technologies (QRT)'s FFTY Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of CapForce IBD 50 ETF (FFTY) in Q3 2024, closing a stake of 2 shares — an estimated $56 sold.

Qube Research & Technologies (QRT) first reported a position in FFTY in Q2 2021 and held it in 5 quarters. The position peaked at $345K in Q2 2021. 29 funds tracked by Wall St. Rank hold FFTY as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining CapForce IBD 50 ETF position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2 CapForce IBD 50 ETF shares in Q3 2024, an estimated $56.
  • Qube Research & Technologies (QRT) first reported a position in CapForce IBD 50 ETF in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s CapForce IBD 50 ETF position peaked at $345K in Q2 2021.
  • 29 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.